Scancell announces positive data from the first stage in its Phase 2 SCOPE trial with SCIB1 cancer vaccine delivered by needle free injection for advanced melanoma To download click here Tuesday 19 September 2023 07:00 Categories: News Regulatory News SCIB1 Year - 2023
Scancell to present three posters at the Seventh International Cancer Immunotherapy Conference To download click here Thursday 14 September 2023 09:01 Categories: News Regulatory News Year - 2023
Scancell Appoints Dr Mandeep Sehmi as Head of Business Development To download click here Thursday 7 September 2023 07:00 Categories: News Regulatory News Year - 2023
Scancell Appoints Sath Nirmalananthan as Chief Financial Officer Keith Green to retire as Director of Finance but to remain as Company Secretary To download click here Tuesday 29 August 2023 10:34 Categories: News Regulatory News Year - 2023
Modi-1 trial open for expansion in combination with checkpoint inhibitors To download click here Monday 31 July 2023 08:53 Categories: Modi-1 Moditope News Regulatory News Year - 2023
Extension of exercise period for CEO share options To download click here Thursday 13 July 2023 09:47 Categories: News Regulatory News Year - 2023
Pipeline strategy and business update To download click here Monday 10 July 2023 11:58 Categories: Modi-1 News Regulatory News SCIB1 Year - 2023
Scancell to present ModiFY Phase 1/2 cancer vaccine clinical trial protocol and early efficacy data at the American Society of Clinical Oncology Meeting To download click here Friday 2 June 2023 10:15 Categories: Modi-1 Moditope News Regulatory News Year - 2023
Issue of share options to Non-Executive Directors To download click here Friday 21 April 2023 08:53 Categories: News Regulatory News Year - 2023
Scancell to present ModiFY Phase 1/2 cancer vaccine clinical trial protocol and early efficacy data at the American Association for Cancer Research Annual Meeting To download click here Tuesday 18 April 2023 07:00 Categories: Modi-1 Moditope News Regulatory News Year - 2023